Apple’s latest smartwatch, the Series 11, has received FDA approval for a new hypertension‑alert feature. The function uses the watch’s optical heart sensor combined with a machine‑learning algorithm trained on a study of more than 100,000 participants. It monitors users for a month‑long period to detect patterns that may indicate high blood pressure, then notifies them of a possible risk. Apple says the feature will roll out in 150 countries when the Series 11 and Ultra 3 launch on September 19. The approval follows earlier FDA clearances for Apple’s OTC hearing‑aid capability and sleep‑apnea detection, even as the company faces a lawsuit over its blood‑oxygen sensor redesign. Leia mais →

Apple’s latest smartwatch, the Series 11, has received FDA approval for a new hypertension‑alert feature. The function uses the watch’s optical heart sensor combined with a machine‑learning algorithm trained on a study of more than 100,000 participants. It monitors users for a month‑long period to detect patterns that may indicate high blood pressure, then notifies them of a possible risk. Apple says the feature will roll out in 150 countries when the Series 11 and Ultra 3 launch on September 19. The approval follows earlier FDA clearances for Apple’s OTC hearing‑aid capability and sleep‑apnea detection, even as the company faces a lawsuit over its blood‑oxygen sensor redesign. Leia mais →

Apple’s latest smartwatch, the Series 11, has received FDA approval for a new hypertension‑alert feature. The function uses the watch’s optical heart sensor combined with a machine‑learning algorithm trained on a study of more than 100,000 participants. It monitors users for a month‑long period to detect patterns that may indicate high blood pressure, then notifies them of a possible risk. Apple says the feature will roll out in 150 countries when the Series 11 and Ultra 3 launch on September 19. The approval follows earlier FDA clearances for Apple’s OTC hearing‑aid capability and sleep‑apnea detection, even as the company faces a lawsuit over its blood‑oxygen sensor redesign. Leia mais →

Apple’s latest smartwatch, the Series 11, has received FDA approval for a new hypertension‑alert feature. The function uses the watch’s optical heart sensor combined with a machine‑learning algorithm trained on a study of more than 100,000 participants. It monitors users for a month‑long period to detect patterns that may indicate high blood pressure, then notifies them of a possible risk. Apple says the feature will roll out in 150 countries when the Series 11 and Ultra 3 launch on September 19. The approval follows earlier FDA clearances for Apple’s OTC hearing‑aid capability and sleep‑apnea detection, even as the company faces a lawsuit over its blood‑oxygen sensor redesign. Leia mais →

Apple’s latest smartwatch, the Series 11, has received FDA approval for a new hypertension‑alert feature. The function uses the watch’s optical heart sensor combined with a machine‑learning algorithm trained on a study of more than 100,000 participants. It monitors users for a month‑long period to detect patterns that may indicate high blood pressure, then notifies them of a possible risk. Apple says the feature will roll out in 150 countries when the Series 11 and Ultra 3 launch on September 19. The approval follows earlier FDA clearances for Apple’s OTC hearing‑aid capability and sleep‑apnea detection, even as the company faces a lawsuit over its blood‑oxygen sensor redesign. Leia mais →